Clinical Trial Update: Transcriptomic Profile of Adipose Tissue Following n-3 Polyunsaturated Fatty Acid (PUFA) Supplementation [NA]

View source ↗

Summary

Completed clinical trial evaluating transcriptomic changes in adipose tissue following omega-3 PUFA supplementation in women with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The Adelaide and Meath Hospital | Conditions: Polycystic Ovary Syndrome | NA | Status: COMPLETED